Orally bioavailable CCI-779 tablet formulations

Details for Australian Patent Application No. 2006214021 (hide)

Owner Wyeth

Inventors Boni, Joseph P.; Banjamin, Eric J.; Ashraf, Muhammad

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2006214021

PCT Pub. Number WO2006/089312

Priority 60/652,889 15.02.05 US

Filing date 13 February 2006

Wipo publication date 24 August 2006

International Classifications

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/48 (2006.01) Medicinal preparations characterised by special physical form - Preparations in capsules, e.g. of gelatin, of chocolate

A61K 31/4745 (2006.01)

Event Publications

30 August 2007 PCT application entered the National Phase

  PCT publication WO2006/089312 Priority application(s): WO2006/089312

14 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006214025-Marine drive

2006214018-Method of treating atherosclerosis, dyslipidemias and related conditions